Your browser doesn't support javascript.
loading
Enhanced BNT162b2 vaccine-induced cellular immunity in anti-CD19 CAR T cell-treated patients.
Oh, Bernice Ling Zhi; Tan, Nicole; de Alwis, Ruklanthi; Kunasegaran, Kamini; Chen, Zhiwei; Poon, Michelle; Chan, Esther; Low, Jenny G H; Yeoh, Allen Eng Juh; Bertoletti, Antonio; Le Bert, Nina.
Afiliação
  • Oh BLZ; VIVA-University Children's Cancer Centre, Khoo-Teck Puat-National University Children's Medical Institute, National University Hospital, Singapore, Singapore.
  • Tan N; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • de Alwis R; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
  • Kunasegaran K; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
  • Chen Z; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore.
  • Poon M; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
  • Chan E; VIVA-University Children's Cancer Centre, Khoo-Teck Puat-National University Children's Medical Institute, National University Hospital, Singapore, Singapore.
  • Low JGH; Department of Haematology-Oncology, National University Cancer Institute of Singapore, National University Health System, Singapore, Singapore; and.
  • Yeoh AEJ; Department of Haematology-Oncology, National University Cancer Institute of Singapore, National University Health System, Singapore, Singapore; and.
  • Bertoletti A; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
  • Le Bert N; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore.
Blood ; 140(2): 156-160, 2022 07 14.
Article em En | MEDLINE | ID: mdl-35472242
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / COVID-19 / Vacina BNT162 / Imunidade Celular Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Singapura
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / COVID-19 / Vacina BNT162 / Imunidade Celular Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Singapura